Dr. Elizabeth Holt, LifeScan Global Corporation, United States
Dr. Elizabeth H. Holt, M.D., F.A.C.E., is a distinguished endocrinologist and global medical leader with extensive expertise in diabetes care, metabolic disorders, and clinical research. As the Head of Global Medical, Clinical, and Safety at LifeScan, she oversees medical strategy, research initiatives, and product safety in diabetes management. She has held prestigious academic roles, including Assistant Consulting Professor of Medicine at Duke University School of Medicine, and has contributed significantly to endocrinology research, with numerous peer-reviewed publications. With a career spanning private practice, academia, and industry leadership, Dr. Holt has been recognized for her contributions to advancing diabetes technology, improving patient outcomes, and leading innovative healthcare solutions on a global scale.
🌍 Professional Profile:
Orcid
🏆 Suitability for the Best Researcher AwardÂ
Dr. Holt is a highly deserving candidate for the Best Researcher Award, given her significant contributions to endocrinology, diabetes management, and metabolic disorders. Her research focuses on improving glycemic control through digital health technologies, continuous glucose monitoring, and innovative diabetes treatments. As a lead investigator in multiple clinical trials, she has played a crucial role in advancing evidence-based diabetes care. Her extensive publication record in top-tier journals highlights her impact on the medical field. Additionally, her leadership roles in LifeScan, Duke University, and AACE reflect her commitment to research excellence. Dr. Holt’s work has not only advanced medical science but also directly improved patient care and diabetes management worldwide.
🎓 EducationÂ
Dr. Holt holds a Bachelor of Science in Zoology from Duke University, where she graduated Magna Cum Laude. She earned her Doctor of Medicine (M.D.) from Bowman Gray School of Medicine and the University of Medicine and Dentistry of New Jersey. She completed her Internal Medicine residency at Moses H. Cone Memorial Hospital in Greensboro, NC, followed by a fellowship in Endocrinology, Diabetes, and Metabolism at the University of North Carolina at Chapel Hill. Her education has provided a solid foundation in clinical endocrinology, metabolic research, and patient-centered care, shaping her into a leading expert in diabetes treatment and metabolic disorders.
🏢 Work ExperienceÂ
Dr. Holt has over 30 years of experience in endocrinology, diabetes research, and clinical practice. She served as a Senior Director of Medical Affairs at Intarcia Therapeutics before assuming her current role as Head of Global Medical, Clinical, and Safety at LifeScan, where she oversees diabetes research and innovation. Previously, she spent 27 years in private practice at Raleigh Endocrine Associates, specializing in diabetes care and metabolic disorders. Dr. Holt has also held academic roles at Duke University, conducted extensive clinical research, and played key leadership roles in AACE, ACE, and other professional organizations. Her broad experience spans patient care, clinical trials, medical leadership, and global health initiatives, making her a leader in the field.
🏅 Awards and HonorsÂ
Dr. Holt has received numerous awards recognizing her contributions to endocrinology, diabetes research, and patient care. She has been named “America’s Top Physician” (2003, 2009, 2011, 2013, 2014) and received the Patients’ Choice Award (2008, 2009, 2011, 2012) for excellence in patient care. She was also honored as Top Endocrinologist in Raleigh, NC (2015, 2017) and Top Doctor by The Global Directory of Who’s Who (2017, 2019). Most recently, she was awarded Top Endocrinologist by The Best in North Carolina Magazine (2020, 2024) and recognized as an Honored Listee by Marquis Who’s Who (2024). These accolades underscore her exceptional contributions to diabetes research, clinical care, and medical education.
🔬 Research FocusÂ
Dr. Holt’s research focuses on diabetes management, continuous glucose monitoring (CGM), and digital health innovations. She has conducted clinical trials on diabetes technology, exploring how Bluetooth-connected glucose meters and mobile health applications improve glycemic control and patient outcomes. Her work on CGM device performance, patient engagement, and metabolic regulation has been widely published in top journals like Diabetes Technology & Therapeutics and Journal of Diabetes Science and Technology. Dr. Holt’s research is data-driven and patient-centered, with a strong emphasis on real-world evidence to enhance diabetes care and treatment adherence. Her contributions have shaped global diabetes management strategies, making her a pioneer in endocrine research and digital therapeutics.
đź“Š Publication Top Notes:
-
Dynamic Interference Testing—Unexpected Results Obtained with the Abbott Libre 2 and Dexcom G6 Continuous Glucose Monitoring Devices
-
Improved Glycemic Outcomes in People with Type 2 Diabetes Using Smart Blood Glucose Monitoring Integrated with Popular Digital Health Therapeutics
-
Glycemic Trends, App Engagement, and Achievement of Gestational Diabetes Guideline Targets Using a Diabetes App and Bluetooth® Connected Blood Glucose Meters
-
Improved Glycemic Outcomes in More Than 55,000 People of Medicare Age With Type 2 Diabetes Using a Mobile Diabetes App With Bluetooth-Connected Blood Glucose Meters
-
Clinical Practice Experiences Using a Professional Diabetes Management Ecosystem During COVID